Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Ultomiris approved in the EU for children and adolescents with paroxysmal nocturnal haemoglobinuria
-
AstraZeneca lung and breast cancer data at WCLC and ESMO 2021 underscore ambition to revolutionise outcomes for patients
-
Forxiga approved in Japan for the treatment of chronic kidney disease in patients with and without type-2 diabetes
-
ALXN1840 FoCus Phase III trial in Wilson disease met primary endpoint demonstrating improvement in copper mobilisation from tissues
-
Update on CHAMPION-ALS Phase III trial of Ultomiris in amyotrophic lateral sclerosis
-
AZD7442 PROVENT Phase III prophylaxis trial met primary endpoint in preventing COVID-19
-
Update on US regulatory review of roxadustat in anaemia of chronic kidney disease
-
Forxiga approved in the EU for the treatment of chronic kidney disease in patients with and without type-2 diabetes
-
Enhertu significantly improved progression-free survival in DESTINY-Breast03 head-to-head trial vs. trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer
-
Saphnelo (anifrolumab) approved in the US for moderate to severe systemic lupus erythematosus
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
